163 related articles for article (PubMed ID: 12082199)
1. Bleeding complications of platelet glycoprotein IIb/IIIa inhibitor abciximab (ReoPro ).
Trivedi SM; Shani J; Hollander G
J Invasive Cardiol; 2002 Jul; 14(7):423-5. PubMed ID: 12082199
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention.
Suleiman M; Gruberg L; Hammerman H; Aronson D; Halabi M; Goldberg A; Grenadier E; Boulus M; Markiewicz W; Beyar R
J Invasive Cardiol; 2003 Jun; 15(6):319-23. PubMed ID: 12777670
[TBL] [Abstract][Full Text] [Related]
3. Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials.
Memon MA; Blankenship JC; Wood GC; Frey CM; Menapace FJ
Am J Med; 2000 Aug; 109(3):213-7. PubMed ID: 10974184
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
Merlini PA; Rossi M; Menozzi A; Buratti S; Brennan DM; Moliterno DJ; Topol EJ; Ardissino D
Circulation; 2004 May; 109(18):2203-6. PubMed ID: 15117843
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group.
Berkowitz SD; Sane DC; Sigmon KN; Shavender JH; Harrington RA; Tcheng JE; Topol EJ; Califf RM
J Am Coll Cardiol; 1998 Aug; 32(2):311-9. PubMed ID: 9708455
[TBL] [Abstract][Full Text] [Related]
6. Bolus-only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention.
Marmur JD; Poludasu S; Agarwal A; Vladutiu P; Feit A; Lapin R; Cavusoglu E
J Invasive Cardiol; 2006 Nov; 18(11):521-6. PubMed ID: 17090813
[TBL] [Abstract][Full Text] [Related]
7. Effects of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel: a meta-analysis of randomized trials.
Pannu R; Andraws R
Crit Pathw Cardiol; 2008 Mar; 7(1):5-10. PubMed ID: 18458661
[TBL] [Abstract][Full Text] [Related]
8. Acute profound thrombocytopenia following abciximab therapy.
Bishara AI; Hagmeyer KO
Ann Pharmacother; 2000; 34(7-8):924-30. PubMed ID: 10928405
[TBL] [Abstract][Full Text] [Related]
9. Platelet receptor glycoprotein IIb/IIIa inhibition with eptifibatide in a patient with thrombocytopenia after treatment with abciximab.
Coto H
J Invasive Cardiol; 2000 Oct; 12(10):528-31. PubMed ID: 11022214
[TBL] [Abstract][Full Text] [Related]
10. Hemorrhagic and vascular complications after percutaneous coronary intervention with adjunctive abciximab.
Cote AV; Berger PB; Holmes DR; Scott CG; Bell MR
Mayo Clin Proc; 2001 Sep; 76(9):890-6. PubMed ID: 11560299
[TBL] [Abstract][Full Text] [Related]
11. Acute profound thrombocytopenia without bleeding complications after re-administration of abciximab.
Nguyen N; Salib H; Mascarenhas DA
J Invasive Cardiol; 2001 Jan; 13(1):56-8. PubMed ID: 11146690
[TBL] [Abstract][Full Text] [Related]
12. Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
Marmur JD; Mitre CA; Barnathan E; Cavusoglu E
Am Heart J; 2006 Nov; 152(5):876-81. PubMed ID: 17070148
[TBL] [Abstract][Full Text] [Related]
13. Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab.
Dangas G; Badimon JJ; Coller BS; Fallon JT; Sharma SK; Hayes RM; Meraj P; Ambrose JA; Marmur JD
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1342-9. PubMed ID: 9714143
[TBL] [Abstract][Full Text] [Related]
14. Profound thrombocytopenia caused by abciximab infusion following.
Daley B; Miranda D; Kalra A; Pease D
Minn Med; 2014 Oct; 97(10):48-9. PubMed ID: 25651641
[No Abstract] [Full Text] [Related]
15. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
Lenderink T; Boersma E; Ruzyllo W; Widimsky P; Ohman EM; Armstrong PW; Wallentin L; Simoons ML;
Am Heart J; 2004 May; 147(5):865-73. PubMed ID: 15131544
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of abciximab readministration in coronary intervention.
Madan M; Kereiakes DJ; Hermiller JB; Rund MM; Tudor G; Anderson L; McDonald MB; Berkowitz SD; Sketch MH; Phillips HR; Tcheng JE
Am J Cardiol; 2000 Feb; 85(4):435-40. PubMed ID: 10728946
[TBL] [Abstract][Full Text] [Related]
17. Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction.
Jong P; Cohen EA; Batchelor W; Lazzam C; Kreatsoulas C; Natarajan MK; Strauss BH
Am Heart J; 2001 Feb; 141(2):218-25. PubMed ID: 11174335
[TBL] [Abstract][Full Text] [Related]
18. Platelet glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: IIb or Not IIb, what is the question?
Young JJ; Kereiakes DJ
J Invasive Cardiol; 2002 Jul; 14(7):404-10. PubMed ID: 12082194
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
Kereiakes DJ; Berkowitz SD; Lincoff AM; Tcheng JE; Wolski K; Achenbach R; Melsheimer R; Anderson K; Califf RM; Topol EJ
Am Heart J; 2000 Jul; 140(1):74-80. PubMed ID: 10874266
[TBL] [Abstract][Full Text] [Related]
20. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
Ferguson JJ; Antman EM; Bates ER; Cohen M; Every NR; Harrington RA; Pepine CJ; Theroux P;
Am Heart J; 2003 Oct; 146(4):628-34. PubMed ID: 14564315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
